Eric Popp represents high growth and public companies in the technology and healthcare industries, assisting clients in matters ranging from formation and corporate governance to complex transactions including venture capital financings, IPOs and acquisitions. Eric also represents venture capital and other investors in connection with their investments and strategic acquisitions.

Download full bio 


  • Evisort Closes $35 Million Series B 

  • Milestone Pharmaceuticals – $95 Million IPO 

  • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 

  • Thriveworks Closes Series B Financing 


  • Boston College Law School
    JD, cum laude, 2018

  • University of Massachusetts Amherst
    BA, Economics

Admissions & Credentials